Empowered by Tyler Technologies
Refine Results

The population density of Florida was 384 in 2018. The population density of Texas was 107 in 2018.

Population Density

Population Density is computed by dividing the total population by Land Area Per Square Mile.

Above charts are based on data from the U.S. Census American Community Survey | ODN Dataset | API - Notes:

1. ODN datasets and APIs are subject to change and may differ in format from the original source data in order to provide a user-friendly experience on this site.

2. To build your own apps using this data, see the ODN Dataset and API links.

3. If you use this derived data in an app, we ask that you provide a link somewhere in your applications to the Open Data Network with a citation that states: "Data for this application was provided by the Open Data Network" where "Open Data Network" links to http://opendatanetwork.com. Where an application has a region specific module, we ask that you add an additional line that states: "Data about REGIONX was provided by the Open Data Network." where REGIONX is an HREF with a name for a geographical region like "Seattle, WA" and the link points to this page URL, e.g. http://opendatanetwork.com/region/1600000US5363000/Seattle_WA

Geographic and Population Datasets Involving Texas or Florida

  • API

    Key Economic Indicators

    data.texas.gov | Last Updated 2024-05-21T13:17:28.000Z

    An economic indicator is a statistic about an economic activity, and they allow analysis of economic performance and predictions of current and future economic performance. The TX Comptroller’s Key Economic Indicators includes such measures for TX & the US employment and unemployment, consumer confidence, price inflation, housing data, etc. See https://comptroller.texas.gov/about/policies/privacy.php for more information on our agency’s privacy and security policies.

  • API

    CPI 1.1 Texas Child Population (ages 0-17) by County 2014-2023

    data.texas.gov | Last Updated 2024-01-30T20:42:33.000Z

    As recommended by the Health and Human Services Commission (HHSC) to ensure consistency across all HHSC agencies, in 2012 DFPS adopted the HHSC methodology on how to categorize race and ethnicity. As a result, data broken down by race and ethnicity in 2012 and after is not directly comparable to race and ethnicity data in 2011 and before. The population totals may not match previously printed DFPS Data Books. Past population estimates are adjusted based on the U.S. Census data as it becomes available. This is important to keep the data in line with current best practices, but may cause some past counts, such as Abuse/Neglect Victims per 1,000 Texas Children, to be recalculated. Population Data Source - Population Estimates and Projections Program, Texas State Data Center, Office of the State Demographer and the Institute for Demographic and Socioeconomic Research, The University of Texas at San Antonio. Current population estimates and projections data as of December 2020. Visit dfps.texas.gov for information on all DFPS programs.

  • API

    Rates of COVID-19 Cases or Deaths by Age Group and Vaccination Status

    data.cdc.gov | Last Updated 2023-07-20T16:01:58.000Z

    Data for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Vaccination Status. Click 'More' for important dataset description and footnotes Dataset and data visualization details: These data were posted on October 21, 2022, archived on November 18, 2022, and revised on February 22, 2023. These data reflect cases among persons with a positive specimen collection date through September 24, 2022, and deaths among persons with a positive specimen collection date through September 3, 2022. Vaccination status: A person vaccinated with a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. Additional or booster dose: A person vaccinated with a primary series and an additional or booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after receipt of an additional or booster dose of any COVID-19 vaccine on or after August 13, 2021. For people ages 18 years and older, data are graphed starting the week including September 24, 2021, when a COVID-19 booster dose was first recommended by CDC for adults 65+ years old and people in certain populations and high risk occupational and institutional settings. For people ages 12-17 years, data are graphed starting the week of December 26, 2021, 2 weeks after the first recommendation for a booster dose for adolescents ages 16-17 years. For people ages 5-11 years, data are included starting the week of June 5, 2022, 2 weeks after the first recommendation for a booster dose for children aged 5-11 years. For people ages 50 years and older, data on second booster doses are graphed starting the week including March 29, 2022, when the recommendation was made for second boosters. Vertical lines represent dates when changes occurred in U.S. policy for COVID-19 vaccination (details provided above). Reporting is by primary series vaccine type rather than additional or booster dose vaccine type. The booster dose vaccine type may be different than the primary series vaccine type. ** Because data on the immune status of cases and associated deaths are unavailable, an additional dose in an immunocompromised person cannot be distinguished from a booster dose. This is a relevant consideration because vaccines can be less effective in this group. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Rates of COVID-19 deaths by vaccination status are reported based on when the patient was tested for COVID-19, not the date they died. Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 31 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), North Carolina, Philadelphia (Pennsylvania), Rhode Island, South Dakota, Tennessee, Texas, Utah, Washington, and West Virginia; 30 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 72% of the total U.S. population and all ten of the Health and Human Services Regions. Data on cases

  • API

    Rates of COVID-19 Cases or Deaths by Age Group and Vaccination Status and Booster Dose

    data.cdc.gov | Last Updated 2023-06-09T00:47:32.000Z

    Data for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Vaccination Status. Click 'More' for important dataset description and footnotes Dataset and data visualization details: These data were posted on October 21, 2022, archived on November 18, 2022, and revised on February 22, 2023. These data reflect cases among persons with a positive specimen collection date through September 24, 2022, and deaths among persons with a positive specimen collection date through September 3, 2022. Vaccination status: A person vaccinated with a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. Additional or booster dose: A person vaccinated with a primary series and an additional or booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after receipt of an additional or booster dose of any COVID-19 vaccine on or after August 13, 2021. For people ages 18 years and older, data are graphed starting the week including September 24, 2021, when a COVID-19 booster dose was first recommended by CDC for adults 65+ years old and people in certain populations and high risk occupational and institutional settings. For people ages 12-17 years, data are graphed starting the week of December 26, 2021, 2 weeks after the first recommendation for a booster dose for adolescents ages 16-17 years. For people ages 5-11 years, data are included starting the week of June 5, 2022, 2 weeks after the first recommendation for a booster dose for children aged 5-11 years. For people ages 50 years and older, data on second booster doses are graphed starting the week including March 29, 2022, when the recommendation was made for second boosters. Vertical lines represent dates when changes occurred in U.S. policy for COVID-19 vaccination (details provided above). Reporting is by primary series vaccine type rather than additional or booster dose vaccine type. The booster dose vaccine type may be different than the primary series vaccine type. ** Because data on the immune status of cases and associated deaths are unavailable, an additional dose in an immunocompromised person cannot be distinguished from a booster dose. This is a relevant consideration because vaccines can be less effective in this group. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Rates of COVID-19 deaths by vaccination status are reported based on when the patient was tested for COVID-19, not the date they died. Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 31 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), North Carolina, Philadelphia (Pennsylvania), Rhode Island, South Dakota, Tennessee, Texas, Utah, Washington, and West Virginia; 30 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 72% of the total U.S. population and all ten of the Health and Human Services Regions. Data on cases

  • API

    CPS 2.4 Children In Legal Responsibility on August 31 by Legal Status and Average Days in Care FY2014-2023

    data.texas.gov | Last Updated 2024-02-12T18:17:38.000Z

    Children in DFPS custody are those for whom a court has appointed DFPS legal responsibility through temporary or permanent managing conservatorship or other court ordered legal basis. This chart includes any child in DFPS custody on August 31 of the fiscal year. A description of the different types of legal statuses is in the CPS glossary: https://www.dfps.texas.gov/About_DFPS/Data_Book/Child_Protective_Services/Resources/glossary.asp Visit dfps.texas.gov for information on Children In Legal Responsibility and all DFPS programs.

  • API

    Strategic Measure_Cost of City Services per Capita Adjusted for Inflation (General Fund only)

    datahub.austintexas.gov | Last Updated 2023-04-10T13:40:21.000Z

    This dataset has information about the cost of providing General Fund City services per capita of the Full Purpose City population (SD23 measure GTW.A.4). It provides expense information from the annual approved budget document (General Fund Summary and Budget Stabilization Reserve Fund Summary) and population information from the City Demographer's Full Purpose Population numbers. The Consumer Price Index information for Texas is available through the following Key Economic Indicators dataset: https://data.texas.gov/dataset/Key-Economic-Indicators/karz-jr5v. This dataset can be used to help understand the cost of city services over time. View more details and insights related to this dataset on the story page: https://data.austintexas.gov/stories/s/ixex-hibp

  • API

    Demographics Stats at a Glance

    datahub.austintexas.gov | Last Updated 2024-05-16T18:54:24.000Z

    These are the statistics listed in the "Stats at a Glance" section of the City of Austin demographics website: https://demographics-austin.hub.arcgis.com/

  • API

    HE.C.2 Peer Cities Table V3

    datahub.austintexas.gov | Last Updated 2024-05-24T16:51:14.000Z

    PARD’s Long Range Plan for Land, Facilities and Programs, Our Parks, Our Future (adopted November 2019) compared Austin’s park system to five peer cities: Atlanta, GA, Dallas, TX, Portland, OR, San Antonio, TX, and San Diego, CA. The peer cities were selected based on characteristics such as population, size, density, and governance type. Portland and San Diego were selected as aspirational cities known for their park systems. Note that the table below presents each scoring area’s 1 to 100 index, where 100 is the highest possible score.

  • API

    FY 2021_NCVAS Population Data For State Summaries

    www.datahub.va.gov | Last Updated 2023-08-25T19:49:04.000Z

    This dataset is comprised of 1-year estimate data from the American Community Survey published as of 2021.

  • API

    Strategic Measure_EOA.C.6 Number and percentage of residents that are living in an area considered to be a Complete Community

    datahub.austintexas.gov | Last Updated 2024-03-26T17:39:18.000Z

    A resident in a complete community is someone residing in an area that is within a 20 minute walk to multiple essential destinations. Calculation method: This study measured the distance and time it takes for a pedestrian to reach five essential destination, or "indicators," from any point across the city using the existing network of sidewalks and crossings within a 20-minute walk time. Using GIS software, this evaluation resulted in a rasterized overlay of geographic outlines of “walksheds” surrounding each indicator destination. Residential estimates were found using an internal database of residential housing units and applied density assumptions and should not be compared to other demographic datasets. Data was sourced from City of Austin, CapMetro, and Austin ISD. View more details and insights related to this data set on the story page: https://data.austintexas.gov/stories/s/rw4g-mrjp